Advanced Drug Delivery Systems for Transdermal Delivery of Non-Steroidal Anti-Inflammatory Drugs: A Review PU Lalit Kumar, Shivani Verma, Mehakjot Singh, Tamanna Tamanna Current Drug Delivery, 2018 | 94 | 2018 |
Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review L Kumar, S Verma, A Bhardwaj, S Vaidya, B Vaidya Artificial cells, nanomedicine, and biotechnology 42 (1), 32-46, 2014 | 77 | 2014 |
Oleic acid vesicles: a new approach for topical delivery of antifungal agent S Verma, A Bhardwaj, M Vij, P Bajpai, N Goutam, L Kumar Artificial cells, nanomedicine, and biotechnology 42 (2), 95-101, 2014 | 75 | 2014 |
Nanotechnology: a magic bullet for HIV AIDS treatment L Kumar, S Verma, DN Prasad, A Bhardwaj, B Vaidya, AK Jain Artificial cells, nanomedicine, and biotechnology 43 (2), 71-86, 2015 | 66 | 2015 |
Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis A Bhardwaj, L Kumar, RK Narang, RSR Murthy Artificial cells, nanomedicine, and biotechnology 41 (1), 52-59, 2013 | 54 | 2013 |
Ethanol based vesicular carriers in transdermal drug delivery: nanoethosomes and transethosomes in focus C Nicolini NanoWorld journal 1 (2), 2016 | 49 | 2016 |
Exosomes: natural carriers for siRNA delivery L Kumar, S Verma, B Vaidya, V Gupta Current pharmaceutical design 21 (31), 4556-4565, 2015 | 41 | 2015 |
Stimuli-sensitive Systems-an emerging delivery system for drugs A Bhardwaj, L Kumar, S Mehta, A Mehta Artificial cells, nanomedicine, and biotechnology 43 (5), 299-310, 2015 | 38 | 2015 |
Formulation and Characterization of Transethosomes for Enhanced Transdermal Delivery of Propranolol Hydrochloride PU Lalit Kumar Micro and Nanosystems, 2019 | 35* | 2019 |
Fatty acid vesicles acting as expanding horizon for transdermal delivery L Kumar, S Verma, S Kumar, DN Prasad, AK Jain Artificial cells, nanomedicine, and biotechnology 45 (2), 251-260, 2017 | 31 | 2017 |
Nanofiber as a novel vehicle for transdermal delivery of therapeutic agents: challenges and opportunities PUSS Lalit Kumar, Shivani Verma, Kajal Joshi Future Journal of Pharmaceutical Sciences, 175, 2021 | 23 | 2021 |
Nanotechnological Carriers for Treatment of Acne. LK Shivani Verma, Puneet Utreja Recent Patents on Anti-Infective Drug Discovery 13 (2), 105-126, 2018 | 20* | 2018 |
Polymeric microparticles-based formulation for the eradication of cutaneous candidiasis: development and characterization L Kumar, S Verma, S Jamwal, S Vaidya, B Vaidya Pharmaceutical development and technology 19 (3), 318-325, 2014 | 19 | 2014 |
Bioadhesive Polymers for Targeted Drug Delivery L Kumar, S Verma, B Vaidya, V Gupta Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and …, 2017 | 17 | 2017 |
Nanocarriers assisted antimicrobial therapy against intracellular pathogens L Kumar, S Verma, B Vaidya, NK Mehra Nanostructures for antimicrobial Therapy 13, 293-324, 2017 | 14 | 2017 |
Gold nanoparticles and their applications in cancer treatment S Verma, P Utreja, M Rahman, L Kumar Current Nanomedicine, 2018 | 13 | 2018 |
Asymmetric membrane capsule (AMC): an useful osmotic drug delivery system L Kumar, KA Shivani, D Parashar, S Bhadra Int J Pharm Pharm Sci 4 (2), 54-59, 2012 | 13 | 2012 |
Liposomes for the delivery of streptokinase L Kumar, S Verma, B Vaidya Therapeutic Delivery 8 (10), 855-866, 2017 | 10 | 2017 |
Overview of inorganic nanoparticles: An expanding horizon in tumor therapeutics DK Lalit Kumar, Shivani Verma , Puneet Utreja Recent patents on anti-cancer drug discovery, 10.2174/1574892817666221005094423, 2022 | 7* | 2022 |
Optimisation of a Greener-Approach for the Synthesis of Cyclodextrin-Based Nanosponges for the Solubility Enhancement of Domperidone, a BCS Class II Drug M Vij, D Neha, K Lalit, W Pankaj, UDW Shahid, M Wael A., A Sultan, ... Pharmaceuticals 16 (4), 567, 2023 | 6 | 2023 |